# Etiometry

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/etiometry

- Industry: Healthcare IT
- Headquarters: Boston, US
- Website: www.etiometry.com
- Total disclosed funding: $9M
- Latest round: Series A (Jun 3, 2021)
- Investors on record: 2

## About

Etiometry Inc. develops advanced clinical intelligence solutions for high-acuity care teams, primarily in intensive care units (ICUs), enhancing decision-making and patient outcomes through integrated data visualization and insights.Founded in 2010 and headquartered in Boston, US, Etiometry Inc. specializes in clinical intelligence solutions for hospitals. The company was co-founded by Evan Butler, who has experience in the healthcare technology sector. Etiometry has successfully executed 2 deals, with the most recent deal occurring on June 3, 2021, when the company raised USD 9.000 mn in Series A funding led by SKK Ventures and participated by Shamrock Holdings, bringing the total amount raised to USD 9.000 mn.Etiometry provides a data aggregation and visualization platform designed for intensive care units (ICUs). This platform integrates data from patient monitoring systems, electronic health records, and peripheral devices, offering healthcare providers key physiologic insights and enabling the automation of clinical pathways to improve patient management across various healthcare settings, including pediatric and adult ICUs.Etiometry operates on a subscription-based revenue model, charging annual fees for access to its clinical intelligence platform. Revenue is generated through partnerships with large hospitals and healthcare systems, which may include service fees for implementation and support. The company's flagship AI-powered tools are designed to enhance patient management, making them integral to healthcare providers' operations.Following the Series A funding round in June 2021, Etiometry Inc. plans to utilize the USD 9.000 mn raised to accelerate research and development efforts, expand its leadership team, and drive clinical initiatives. The company is focused on launching new products designed to enhance its platform's capabilities and is exploring expansion into additional urban healthcare markets to broaden its geographical reach in the coming years.

## Funding rounds

- Series A, Jun 3, 2021, $9M — Shepherd Kaplan Krochuk, Shamrock Holdings

## Investors

- Shepherd Kaplan Krochuk (https://capitalatlas.ai/funds/shepherd-kaplan-krochuk) — Series A
- Shamrock Holdings (https://capitalatlas.ai/funds/shamrock-holdings) — Series A